版權說明:本文檔由用戶提供并上傳,收益歸屬內容提供方,若內容存在侵權,請進行舉報或認領
文檔簡介
AntituberculousdrugFirst-lineagents:Isoniazid(INH)RifampinPyrazinamideEthambutol
StreptomycinSecond-lineagents:OfloxacinCiprofloxacinPara-aminosalicylicacidAmikacin
Isoniazid【Antibacterialaction】
IsoniazidhasnarrowantibacterialspectrumItisactiveagainstmycobacteriumtuberculosisItisbacteriostaticinthestationaryphaseitisbactericidalinrapidlydividingorganisms3.Itisabletopenetrateintophagocyticcells
Itinhibitstheenzymeresponsibleforassemblyofmycolicacidsintotheouterlayerofthemycobacteria,【Mechanismofaction
】【Clinicaluses】
Itisusedfortreatmentoflatenttuberculosis.Usuallyitcombinedwithotherdugswasgiventotreattuberculosis.【adverseeffect】
Peripheralneuritis:hand-foottrembling,anesthesia2.Hepatitisandidiosyncratichepatotoxicity:fatalhepatitis3.Otheradverseeffects:mentalabnormalities,seizures,opticneuritis,HypersensitivityreactionsRifampicinRifampinisbactericidalforbothintracellularandextracellular
mycobacteria
Itiseffectiveagainstmanygram(+)andgram(-)organismsRifampinisthemostactiveanti-leprosydrugatpresent.ItblockstranscriptionbyinteractingwithbacterialDNA-dependentRNApolymerase,thusinhibitingRNAsynthesis【ClinicalusesandAdverseeffects】Mycobacterialinfections:
rifampinisadministeredtogetherwithisoniazid,ethambutol,oranotherantituberculousdrug2.Seriousstaphylococcalinfections:
Rifampincombinationtherapyisusefortreatmentofseriousstaphylococcalinfections3.Rifampincausesnausea,vomiting,rash,andfeverAntiviraldrugandantifungalagentSectionIAntiviraldrug一、TreatmentofviralrespiratoryinfectionsAmantadine
RimantadineRibavirin【Antiviralactions】1.Antiviralspectrum:TheyareeffectiveagainstRNAvirusinfluenzaAvirus2.Mechanism:Blocktheviralmembranematrixprotein,M2Interferewiththereleaseofnewvirions
Amantadineandrimantadine【Clinicalusesandadverseeffect
】ItisusedfortreatmentofinfluenzaAinfectionAmantadine:CNSreactioninsomnia,dizziness,ataxia,hallucinations,seizures3.Contraindications:psychiatricproblems,cerebralatherosclerosis,epilepsy;pregnantandnursingmothersRibavirin【Antiviralactions】1.Antiviralspectrum:
RibaviriniseffectiveagainstabroadspectrumofRNAandDNAvirusesRSV,hepatitisAvirus,influenzaAandB2.Mechanism:InhibitingviralmRNAsynthesisRibavirinisusedintreatinginfantsandyoungchildreninfectedwithsevereRSV.ItisalsousedtotreatacutehepatitisAvirusandinfluenzaAandBinfections.RibavirinmayreducethemortalityandviremiaofLassafever.【Clinicaluses
】【Adverseeffect】Transientanemia,elevatedbilirubin.Ribaviriniscontraindicatedinpregnancy二、TreatmentofherpesvirusinfectionsAcyclovirGanciclovir
Acyclovir【Antiviralactionsandclinicaluses】1.AntiviralspectrumAcycloviriseffectiveagainstDNAvirusherpesviruses:herpessimplexvirus-1(HSV-1),HSV-2,varicella-zostervirusandEpstein-Barrvirus,butCMVisresistant2.Acycloviristhetreatmentofchoiceinherpessimplexencephalitis,genitalherpesinfections.【Mechanismofaction】
Acyclovirmonophosphatederivative
InhibitviralDNApolymeraseinhibitsviralDNAsynthesisincorporateintotheviralDNAthymidine
kinase
Acyclovirtriphosphate
host’scelluarenzymes
【Adverseeffect】1.Topicalapplication:
localirritation2.Oraladministration:headache,diarrhea,nausea,andvomiting3.Intravenousinfusion:
phlebitis,transientrenaldysfunction三、TreatmentforAIDSZidovudineDidanosineZalcitabineStavudineLamivudine
ZidovudineZidovudineisaantiretroviralagentsItactbycompetitiveinhibitionofHIV-1reversetranscriptaseandcanalsobeincorporatedintothegrowingviralDNAchaintocausetermination.ItisusedfortreatmentofpatientsinfectedwithHIVAdverseeffectismyelosuppression,gastrointestinalintolerance,headaches,andinsomnia【Features】四、Interferon【Features】Actions:antiviral,immunomodulatory,andantiproliferativeactivitiesUses:treatmentofbothHBVandHCVvirusinfectionsAdverseeffects:fever,lethargy,bonemarrowdepression,cardiovascularproblemsandacutehypersensitivityreactionsSectionIIAntifungalAgentSystemicantifungaldrugsforsystemicinfectionsTopicalantifungaldrugsformucocutaneousinfections一、SystemicantifungaldrugsforsystemicinfectionsAmphotericinBFlucytosine
Ketoconazole
AmphotericinBAntifungalspectrum:
ItiseitherfungistaticorfungicidalItiseffectiveagainstawiderangeoffungi
candida
albicans,Histoplasma
capsulatum,
cryptococcus
neoformans2.Modeofaction:bindtoergosterolincellmembranestoformporesorchannels【Antifungalactions】【Clinicaluses】
Itisoftenusedastheinitialinductionregimenforseriousfungalinfectionsandisthenreplacedbyoneofthenewerazoledrugsforchronictherapyorpreventionofrelapse.【Adverseeffect】Feverandchills,Renalimpairment,Hypotension,Anemia,Neurologicaleffects,ThrombophlebitisFlucytosine
Antifungalspectrum:
FlucytosineisfungistaticandeffectiveagainstCandidamonilia,andCryptococcus.2.Modeofaction:5-FCisconvertedto5-FdUMP,inhibits
thymidylate
synthetase,thusdisruptnucleicacidandproteinsynthesis【Antifungalactions】【Clinicaluses】FlucytosineisusedonlyincombinationwithamphotericinforthetreatmentofsystemicmycosesandmeningitiscausedbyCryptococcusneoformansandCandida.【Adverseeffect】Hematologictoxicity,Hepaticdysfunction,GastrointestinaldisturbancesKetoconazole
【Antifungalactions】Antifungalspectrum:
KetoconazoleiseitherfungistaticorfungicidalItisactiveagainstthe
samefungiasamphotericin
B2.Modeofaction:
Ketoconazoleblocksergosterolsynthesis,increasespermeabilityofcellmembrane【Clinicaluses】
Ketoconazoleismostusefulinthetreatmentofhistoplasmosis,blastomycosis,Candida,andvariousdermatophyticinfections【Adverseeffect】Gastrointestinaldistress,Endocrineeffects,HepaticdysfunctionContraindications:KetoconazoleandamphotericinBshouldnotbeusedtogether.二、DrugsforsuperficialmycosesGriseofulvin
Antifungalspectrum:
griseofulvinisprincipallyfungistaticItiseffectiveonlyagainstthedermatophytes--Trichophyton,Microsporum,andEpidermophyton2.Modeofaction:interactwiththemicrotubulestodisruptthemitoticspindleandinhibitmitosis.【Antifungalactions】【Clinicaluses】Itisusedinthetreatmentofseveretineainfectionsthatdonotrespondtootherantifungalagents.Therapymustbecontinueduntilnormaltissuereplacesinfectedtissue.【Adverseeffect】Allergicreactions,headache,nausea,hepatotoxicity
Summaryofantibacterialdrugsβ–LactamMacrolidesLincosamidesPolypeptidesAminoglycosidesTetracyclinesChloramphenicol
SynthesisantibacterialdrugsClassificationofantibacterialdrugsQuinolonesSulfonamidesAntibioticsβ–Lactamantibacterialdrugs
Penicillins
PenicillinGPenicillinase-resistantpenicillin(Oxacillin)Extendedspectrumpenicillins
(Ampicillin,Amoxicillin)Antipseudomonal
penicillins(Carbenicillin,Piperacillin)PenicillinGGram-positivecoccusGram-negativecoccusGram-positivebacilliHelicoidsPenicillinase-resistantpenicillin(Oxacillin)(1)Theykillpenicillinase-producingstaphylococci(2)Theycan’tkillMethicillin-resistantstrainsofStaphylococcusaureus(MRSA)VancomycinExtendedspectrumpenicillins(Ampicillin,Amoxicillin
)Theyaremoreeffectiveagainstgram-negativebacilliTheycannotkillpseudomonasaeruginosaAntipseudomonal
penicillinsCarbenicillinPiperacillinCephalosporinsFeature+++
First
Second
ThirdG+++++++G-++++++Pseudomonasaeruginosa--+anaerobes-++nephrotoxic+++-MacrolidesBacteriostaticAntibacterialspectrummostG+afewG-Mycoplasma
Chlamydia
Legionella
G+infectionLegionellamycoplasma
ChlamydiapneumoniaAminoglycosidesBactericidalAntibacterialspectrumTheyareeffectiveagainstaerobicgram-negativebacilliTheyareineffectiveagainstanaerobicorganismsTetracyclineandChloramphenicolantibacterialdrugsTetracyclinesChloramphenicolBacteriostatic??G++++++G-+++++anaerobes+++mycoplasma??spirochete??Rickettsia??SynthesisantibacterialdrugsBactericidalAntibacterialspectrumFirstgeneration:someG-Secondgeneration:MoreG-Third:G+,chlamydia,mycoplasma,LegionellaandBacillustuberculosisThefourth:anaerobicbacteriumQuinolonesSulfonamidesantibacterialdrugseffectiveagainstG+
andG-effectiveagainstChlamydiaineffectiveagainstmycoplasma,
Rickettsiaandhelicoid
BacteriostaticAntibacterialspectrumMechanismofactionQuinolonesTetracyclinesAminoglycosides
Macrolides
ChloramphenicolLincomycinPolymyxinPolyenesAzoles
-lactamVancomycinDNAPlasmamembraneCellwallPABADHFATHFA50S50S50S30S30S30SmRNARifampinTMPSulfonamides
溫馨提示
- 1. 本站所有資源如無特殊說明,都需要本地電腦安裝OFFICE2007和PDF閱讀器。圖紙軟件為CAD,CAXA,PROE,UG,SolidWorks等.壓縮文件請下載最新的WinRAR軟件解壓。
- 2. 本站的文檔不包含任何第三方提供的附件圖紙等,如果需要附件,請聯系上傳者。文件的所有權益歸上傳用戶所有。
- 3. 本站RAR壓縮包中若帶圖紙,網頁內容里面會有圖紙預覽,若沒有圖紙預覽就沒有圖紙。
- 4. 未經權益所有人同意不得將文件中的內容挪作商業(yè)或盈利用途。
- 5. 人人文庫網僅提供信息存儲空間,僅對用戶上傳內容的表現方式做保護處理,對用戶上傳分享的文檔內容本身不做任何修改或編輯,并不能對任何下載內容負責。
- 6. 下載文件中如有侵權或不適當內容,請與我們聯系,我們立即糾正。
- 7. 本站不保證下載資源的準確性、安全性和完整性, 同時也不承擔用戶因使用這些下載資源對自己和他人造成任何形式的傷害或損失。
最新文檔
- 二零二五年度購物中心水電維修服務合同(1000字)6篇
- 二零二五年度冷鏈物流食品供應合同3篇
- 二零二五年度環(huán)保材料買賣合同樣本詳述3篇
- 二零二五年度綠色建筑文明施工與環(huán)境保護一體化協議書3篇
- 二零二五年度行政上訴狀編制要點與官方格式3篇
- 二零二五年度企業(yè)委托高校培養(yǎng)博士研究生技術合作協議3篇
- 二零二五年度互聯網醫(yī)療健康品牌授權協議3篇
- 二零二五年度企業(yè)股權激勵協議(限制性股權)6篇
- 二零二五年度農產品銷售承包協議
- 2025版科技研發(fā)園區(qū)物業(yè)管理權轉讓與技術創(chuàng)新服務合同3篇
- 2024年湖南高速鐵路職業(yè)技術學院高職單招(英語/數學/語文)筆試歷年參考題庫含答案解析
- 《活著》讀書分享課件
- 新課標人教版小學數學六年級下冊集體備課教學案全冊表格式
- 校園保潔培訓課件
- 渠道管理就這樣做
- 大客戶銷售這樣說這樣做
- 精裝修樣板房房屋使用說明
- 喬遷新居結婚典禮主持詞
- 小學四年級數學競賽試題(附答案)
- 魯科版高中化學必修2全冊教案
- 人口分布 高一地理下學期人教版 必修第二冊
評論
0/150
提交評論